10x Genomics (TXG) Inventory Average (2019 - 2026)

10x Genomics has disclosed Inventory Average across 8 years of filings, most recently posting $54.9 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $54.9 million, down 30.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.9 million (down 30.41% YoY), and the FY2025 annual result was $69.7 million, down 11.07% from the prior year.
• Inventory Average came in at $54.9 million for Q1 2026 at 10x Genomics, down from $59.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $91.2 million in Q3 2024 to a low of $54.9 million in Q1 2026.
• The 5-year median for Inventory Average is $78.4 million (2024), against an average of $75.4 million.
• Across the five-year window, Inventory Average jumped 80.62% in 2022 and sank 33.22% in 2025, its largest moves.
• 10x Genomics' Inventory Average stood at $80.1 million in 2022, then fell by 3.52% to $77.3 million in 2023, then climbed by 14.57% to $88.6 million in 2024, then tumbled by 33.22% to $59.1 million in 2025, then fell by 7.16% to $54.9 million in 2026.
• The last three Inventory Average figures came in at $54.9 million (Q1 2026), $59.1 million (Q4 2025), and $65.5 million (Q3 2025), per Business Quant data.